img

Global Albendazole Anthelmintic Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Albendazole Anthelmintic Drug Market Insights, Forecast to 2034

Albendazole is an anthelmintic drug used to treat parasitic infections caused by various types of worms and helminths. It works by inhibiting the parasites' ability to absorb nutrients, ultimately causing their death. Albendazole is commonly used to treat conditions like intestinal worms, strongyloidiasis, and neurocysticercosis.
Global Albendazole Anthelmintic Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Albendazole Anthelmintic Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Albendazole Anthelmintic Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Albendazole Anthelmintic Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segment by Type
Tablet
Capsule
Other

Segment by Application


Human
Veterinary

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Albendazole Anthelmintic Drug plant distribution, commercial date of Albendazole Anthelmintic Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Albendazole Anthelmintic Drug introduction, etc. Albendazole Anthelmintic Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Albendazole Anthelmintic Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Albendazole Anthelmintic Drug Product Introduction
1.2 Market by Type
1.2.1 Global Albendazole Anthelmintic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market by Application
1.3.1 Global Albendazole Anthelmintic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Human
1.3.3 Veterinary
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Albendazole Anthelmintic Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Albendazole Anthelmintic Drug Revenue by Region
2.2.1 Global Albendazole Anthelmintic Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Albendazole Anthelmintic Drug Revenue by Region (2018-2024)
2.2.3 Global Albendazole Anthelmintic Drug Revenue by Region (2024-2029)
2.2.4 Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2018-2029)
2.3 Global Albendazole Anthelmintic Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Albendazole Anthelmintic Drug Sales by Region
2.4.1 Global Albendazole Anthelmintic Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Albendazole Anthelmintic Drug Sales by Region (2018-2024)
2.4.3 Global Albendazole Anthelmintic Drug Sales by Region (2024-2029)
2.4.4 Global Albendazole Anthelmintic Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Albendazole Anthelmintic Drug Sales by Manufacturers
3.1.1 Global Albendazole Anthelmintic Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Albendazole Anthelmintic Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Albendazole Anthelmintic Drug in 2022
3.2 Global Albendazole Anthelmintic Drug Revenue by Manufacturers
3.2.1 Global Albendazole Anthelmintic Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Albendazole Anthelmintic Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Albendazole Anthelmintic Drug Revenue in 2022
3.3 Global Key Players of Albendazole Anthelmintic Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Albendazole Anthelmintic Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Albendazole Anthelmintic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Albendazole Anthelmintic Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Albendazole Anthelmintic Drug, Product Offered and Application
3.8 Global Key Manufacturers of Albendazole Anthelmintic Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Albendazole Anthelmintic Drug Sales by Type
4.1.1 Global Albendazole Anthelmintic Drug Historical Sales by Type (2018-2024)
4.1.2 Global Albendazole Anthelmintic Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
4.2 Global Albendazole Anthelmintic Drug Revenue by Type
4.2.1 Global Albendazole Anthelmintic Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Albendazole Anthelmintic Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
4.3 Global Albendazole Anthelmintic Drug Price by Type
4.3.1 Global Albendazole Anthelmintic Drug Price by Type (2018-2024)
4.3.2 Global Albendazole Anthelmintic Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Albendazole Anthelmintic Drug Sales by Application
5.1.1 Global Albendazole Anthelmintic Drug Historical Sales by Application (2018-2024)
5.1.2 Global Albendazole Anthelmintic Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
5.2 Global Albendazole Anthelmintic Drug Revenue by Application
5.2.1 Global Albendazole Anthelmintic Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Albendazole Anthelmintic Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
5.3 Global Albendazole Anthelmintic Drug Price by Application
5.3.1 Global Albendazole Anthelmintic Drug Price by Application (2018-2024)
5.3.2 Global Albendazole Anthelmintic Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Albendazole Anthelmintic Drug Market Size by Type
6.1.1 US & Canada Albendazole Anthelmintic Drug Sales by Type (2018-2029)
6.1.2 US & Canada Albendazole Anthelmintic Drug Revenue by Type (2018-2029)
6.2 US & Canada Albendazole Anthelmintic Drug Market Size by Application
6.2.1 US & Canada Albendazole Anthelmintic Drug Sales by Application (2018-2029)
6.2.2 US & Canada Albendazole Anthelmintic Drug Revenue by Application (2018-2029)
6.3 US & Canada Albendazole Anthelmintic Drug Market Size by Country
6.3.1 US & Canada Albendazole Anthelmintic Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Albendazole Anthelmintic Drug Sales by Country (2018-2029)
6.3.3 US & Canada Albendazole Anthelmintic Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Albendazole Anthelmintic Drug Market Size by Type
7.1.1 Europe Albendazole Anthelmintic Drug Sales by Type (2018-2029)
7.1.2 Europe Albendazole Anthelmintic Drug Revenue by Type (2018-2029)
7.2 Europe Albendazole Anthelmintic Drug Market Size by Application
7.2.1 Europe Albendazole Anthelmintic Drug Sales by Application (2018-2029)
7.2.2 Europe Albendazole Anthelmintic Drug Revenue by Application (2018-2029)
7.3 Europe Albendazole Anthelmintic Drug Market Size by Country
7.3.1 Europe Albendazole Anthelmintic Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Albendazole Anthelmintic Drug Sales by Country (2018-2029)
7.3.3 Europe Albendazole Anthelmintic Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Albendazole Anthelmintic Drug Market Size
8.1.1 China Albendazole Anthelmintic Drug Sales (2018-2029)
8.1.2 China Albendazole Anthelmintic Drug Revenue (2018-2029)
8.2 China Albendazole Anthelmintic Drug Market Size by Application
8.2.1 China Albendazole Anthelmintic Drug Sales by Application (2018-2029)
8.2.2 China Albendazole Anthelmintic Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Albendazole Anthelmintic Drug Market Size by Type
9.1.1 Asia Albendazole Anthelmintic Drug Sales by Type (2018-2029)
9.1.2 Asia Albendazole Anthelmintic Drug Revenue by Type (2018-2029)
9.2 Asia Albendazole Anthelmintic Drug Market Size by Application
9.2.1 Asia Albendazole Anthelmintic Drug Sales by Application (2018-2029)
9.2.2 Asia Albendazole Anthelmintic Drug Revenue by Application (2018-2029)
9.3 Asia Albendazole Anthelmintic Drug Sales by Region
9.3.1 Asia Albendazole Anthelmintic Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Albendazole Anthelmintic Drug Revenue by Region (2018-2029)
9.3.3 Asia Albendazole Anthelmintic Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Huazhong Pharmaceutical
11.2.1 Huazhong Pharmaceutical Company Information
11.2.2 Huazhong Pharmaceutical Overview
11.2.3 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Huazhong Pharmaceutical Recent Developments
11.3 Jiangsu Qihui
11.3.1 Jiangsu Qihui Company Information
11.3.2 Jiangsu Qihui Overview
11.3.3 Jiangsu Qihui Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Jiangsu Qihui Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangsu Qihui Recent Developments
11.4 Sequent Scientific
11.4.1 Sequent Scientific Company Information
11.4.2 Sequent Scientific Overview
11.4.3 Sequent Scientific Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sequent Scientific Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sequent Scientific Recent Developments
11.5 K.A. Malle Pharmaceuticals
11.5.1 K.A. Malle Pharmaceuticals Company Information
11.5.2 K.A. Malle Pharmaceuticals Overview
11.5.3 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 K.A. Malle Pharmaceuticals Recent Developments
11.6 Lasa Supergenerics Limited
11.6.1 Lasa Supergenerics Limited Company Information
11.6.2 Lasa Supergenerics Limited Overview
11.6.3 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lasa Supergenerics Limited Recent Developments
11.7 Zhongjia Pharmaceutical
11.7.1 Zhongjia Pharmaceutical Company Information
11.7.2 Zhongjia Pharmaceutical Overview
11.7.3 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zhongjia Pharmaceutical Recent Developments
11.8 Fredun Pharmaceuticals Ltd
11.8.1 Fredun Pharmaceuticals Ltd Company Information
11.8.2 Fredun Pharmaceuticals Ltd Overview
11.8.3 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fredun Pharmaceuticals Ltd Recent Developments
11.9 Supharma Chem
11.9.1 Supharma Chem Company Information
11.9.2 Supharma Chem Overview
11.9.3 Supharma Chem Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Supharma Chem Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Supharma Chem Recent Developments
11.10 Salius Pharma
11.10.1 Salius Pharma Company Information
11.10.2 Salius Pharma Overview
11.10.3 Salius Pharma Albendazole Anthelmintic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Salius Pharma Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Salius Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Albendazole Anthelmintic Drug Industry Chain Analysis
12.2 Albendazole Anthelmintic Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Albendazole Anthelmintic Drug Production Mode & Process
12.4 Albendazole Anthelmintic Drug Sales and Marketing
12.4.1 Albendazole Anthelmintic Drug Sales Channels
12.4.2 Albendazole Anthelmintic Drug Distributors
12.5 Albendazole Anthelmintic Drug Customers
13 Market Dynamics
13.1 Albendazole Anthelmintic Drug Industry Trends
13.2 Albendazole Anthelmintic Drug Market Drivers
13.3 Albendazole Anthelmintic Drug Market Challenges
13.4 Albendazole Anthelmintic Drug Market Restraints
14 Key Findings in The Global Albendazole Anthelmintic Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Albendazole Anthelmintic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Other
Table 5. Global Albendazole Anthelmintic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Albendazole Anthelmintic Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Albendazole Anthelmintic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Albendazole Anthelmintic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2018-2024)
Table 10. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2024-2029)
Table 11. Global Albendazole Anthelmintic Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Albendazole Anthelmintic Drug Sales by Region (2018-2024) & (K Units)
Table 13. Global Albendazole Anthelmintic Drug Sales by Region (2024-2029) & (K Units)
Table 14. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2018-2024)
Table 15. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2024-2029)
Table 16. Global Albendazole Anthelmintic Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Albendazole Anthelmintic Drug Sales Share by Manufacturers (2018-2024)
Table 18. Global Albendazole Anthelmintic Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Albendazole Anthelmintic Drug Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Albendazole Anthelmintic Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Albendazole Anthelmintic Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Albendazole Anthelmintic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Albendazole Anthelmintic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole Anthelmintic Drug as of 2022)
Table 24. Global Key Manufacturers of Albendazole Anthelmintic Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Albendazole Anthelmintic Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Albendazole Anthelmintic Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Albendazole Anthelmintic Drug Sales by Type (2018-2024) & (K Units)
Table 29. Global Albendazole Anthelmintic Drug Sales by Type (2024-2029) & (K Units)
Table 30. Global Albendazole Anthelmintic Drug Sales Share by Type (2018-2024)
Table 31. Global Albendazole Anthelmintic Drug Sales Share by Type (2024-2029)
Table 32. Global Albendazole Anthelmintic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Albendazole Anthelmintic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Albendazole Anthelmintic Drug Revenue Share by Type (2018-2024)
Table 35. Global Albendazole Anthelmintic Drug Revenue Share by Type (2024-2029)
Table 36. Albendazole Anthelmintic Drug Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Albendazole Anthelmintic Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Albendazole Anthelmintic Drug Sales by Application (2018-2024) & (K Units)
Table 39. Global Albendazole Anthelmintic Drug Sales by Application (2024-2029) & (K Units)
Table 40. Global Albendazole Anthelmintic Drug Sales Share by Application (2018-2024)
Table 41. Global Albendazole Anthelmintic Drug Sales Share by Application (2024-2029)
Table 42. Global Albendazole Anthelmintic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Albendazole Anthelmintic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Albendazole Anthelmintic Drug Revenue Share by Application (2018-2024)
Table 45. Global Albendazole Anthelmintic Drug Revenue Share by Application (2024-2029)
Table 46. Albendazole Anthelmintic Drug Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Albendazole Anthelmintic Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Albendazole Anthelmintic Drug Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Albendazole Anthelmintic Drug Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Albendazole Anthelmintic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Albendazole Anthelmintic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Albendazole Anthelmintic Drug Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Albendazole Anthelmintic Drug Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Albendazole Anthelmintic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Albendazole Anthelmintic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Albendazole Anthelmintic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Albendazole Anthelmintic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Albendazole Anthelmintic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Albendazole Anthelmintic Drug Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Albendazole Anthelmintic Drug Sales by Country (2024-2029) & (K Units)
Table 61. Europe Albendazole Anthelmintic Drug Sales by Type (2018-2024) & (K Units)
Table 62. Europe Albendazole Anthelmintic Drug Sales by Type (2024-2029) & (K Units)
Table 63. Europe Albendazole Anthelmintic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Albendazole Anthelmintic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Albendazole Anthelmintic Drug Sales by Application (2018-2024) & (K Units)
Table 66. Europe Albendazole Anthelmintic Drug Sales by Application (2024-2029) & (K Units)
Table 67. Europe Albendazole Anthelmintic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Albendazole Anthelmintic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Albendazole Anthelmintic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Albendazole Anthelmintic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Albendazole Anthelmintic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Albendazole Anthelmintic Drug Sales by Country (2018-2024) & (K Units)
Table 73. Europe Albendazole Anthelmintic Drug Sales by Country (2024-2029) & (K Units)
Table 74. China Albendazole Anthelmintic Drug Sales by Type (2018-2024) & (K Units)
Table 75. China Albendazole Anthelmintic Drug Sales by Type (2024-2029) & (K Units)
Table 76. China Albendazole Anthelmintic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Albendazole Anthelmintic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Albendazole Anthelmintic Drug Sales by Application (2018-2024) & (K Units)
Table 79. China Albendazole Anthelmintic Drug Sales by Application (2024-2029) & (K Units)
Table 80. China Albendazole Anthelmintic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Albendazole Anthelmintic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Albendazole Anthelmintic Drug Sales by Type (2018-2024) & (K Units)
Table 83. Asia Albendazole Anthelmintic Drug Sales by Type (2024-2029) & (K Units)
Table 84. Asia Albendazole Anthelmintic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Albendazole Anthelmintic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Albendazole Anthelmintic Drug Sales by Application (2018-2024) & (K Units)
Table 87. Asia Albendazole Anthelmintic Drug Sales by Application (2024-2029) & (K Units)
Table 88. Asia Albendazole Anthelmintic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Albendazole Anthelmintic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Albendazole Anthelmintic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Albendazole Anthelmintic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Albendazole Anthelmintic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Albendazole Anthelmintic Drug Sales by Region (2018-2024) & (K Units)
Table 94. Asia Albendazole Anthelmintic Drug Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales by Country (2024-2029) & (K Units)
Table 108. GlaxoSmithKline Company Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. GlaxoSmithKline Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline Recent Developments
Table 113. Huazhong Pharmaceutical Company Information
Table 114. Huazhong Pharmaceutical Description and Major Businesses
Table 115. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Huazhong Pharmaceutical Recent Developments
Table 118. Jiangsu Qihui Company Information
Table 119. Jiangsu Qihui Description and Major Businesses
Table 120. Jiangsu Qihui Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Jiangsu Qihui Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Jiangsu Qihui Recent Developments
Table 123. Sequent Scientific Company Information
Table 124. Sequent Scientific Description and Major Businesses
Table 125. Sequent Scientific Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Sequent Scientific Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sequent Scientific Recent Developments
Table 128. K.A. Malle Pharmaceuticals Company Information
Table 129. K.A. Malle Pharmaceuticals Description and Major Businesses
Table 130. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. K.A. Malle Pharmaceuticals Recent Developments
Table 133. Lasa Supergenerics Limited Company Information
Table 134. Lasa Supergenerics Limited Description and Major Businesses
Table 135. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Lasa Supergenerics Limited Recent Developments
Table 138. Zhongjia Pharmaceutical Company Information
Table 139. Zhongjia Pharmaceutical Description and Major Businesses
Table 140. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Zhongjia Pharmaceutical Recent Developments
Table 143. Fredun Pharmaceuticals Ltd Company Information
Table 144. Fredun Pharmaceuticals Ltd Description and Major Businesses
Table 145. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Fredun Pharmaceuticals Ltd Recent Developments
Table 148. Supharma Chem Company Information
Table 149. Supharma Chem Description and Major Businesses
Table 150. Supharma Chem Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Supharma Chem Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Supharma Chem Recent Developments
Table 153. Salius Pharma Company Information
Table 154. Salius Pharma Description and Major Businesses
Table 155. Salius Pharma Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Salius Pharma Albendazole Anthelmintic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Salius Pharma Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Albendazole Anthelmintic Drug Distributors List
Table 161. Albendazole Anthelmintic Drug Customers List
Table 162. Albendazole Anthelmintic Drug Market Trends
Table 163. Albendazole Anthelmintic Drug Market Drivers
Table 164. Albendazole Anthelmintic Drug Market Challenges
Table 165. Albendazole Anthelmintic Drug Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Albendazole Anthelmintic Drug Product Picture
Figure 2. Global Albendazole Anthelmintic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Albendazole Anthelmintic Drug Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Other Product Picture
Figure 7. Global Albendazole Anthelmintic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Albendazole Anthelmintic Drug Market Share by Application in 2022 & 2029
Figure 9. Human
Figure 10. Veterinary
Figure 11. Albendazole Anthelmintic Drug Report Years Considered
Figure 12. Global Albendazole Anthelmintic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Albendazole Anthelmintic Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Albendazole Anthelmintic Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Albendazole Anthelmintic Drug Sales 2018-2029 ((K Units)
Figure 17. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Albendazole Anthelmintic Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Albendazole Anthelmintic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Albendazole Anthelmintic Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Albendazole Anthelmintic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Albendazole Anthelmintic Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Albendazole Anthelmintic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Albendazole Anthelmintic Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Albendazole Anthelmintic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Albendazole Anthelmintic Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Albendazole Anthelmintic Drug in the World: Market Share by Albendazole Anthelmintic Drug Revenue in 2022
Figure 30. Global Albendazole Anthelmintic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Albendazole Anthelmintic Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Albendazole Anthelmintic Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Albendazole Anthelmintic Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Albendazole Anthelmintic Drug Sales Share by Country (2018-2029)
Figure 49. Germany Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
Figure 55. China Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
Figure 57. China Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Albendazole Anthelmintic Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Albendazole Anthelmintic Drug Sales Share by Region (2018-2029)
Figure 64. Japan Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Albendazole Anthelmintic Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Albendazole Anthelmintic Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Albendazole Anthelmintic Drug Value Chain
Figure 81. Albendazole Anthelmintic Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries